Document Detail

Protective effect of curcumin against cardiac dysfunction in sepsis rats.
MedLine Citation:
PMID:  23336318     Owner:  NLM     Status:  Publisher    
Context: The heart is one of the target organs susceptible to attack by sepsis, and protection of the cardiac function in sepsis or alleviation dysfunction caused by sepsis appears a serious and urgent problem. Objective: This study was designed to explore the effect of curcumin on myocardial injury induced by sepsis and to explore the therapeutic effect of curcumin in managing sepsis induced cardiac dysfunction. Methods: Cecal ligation and puncture surgery were used to establish the sepsis model. Curcumin was administered by peritoneal injection (200 mg/kg/d, 3 days). The effects of curcumin on the cardiac functions [Ejection Fraction (EF), Fractional Shortening (FS), Cardiac Output (CO), Heart Rate (HR)], body temperature, cTn I and superoxide dismutase levels, malondialdehyde content (an index of lipid peroxidation), and myocardial histopathological and ultrastructural studies were carried out. Results: We demonstrated that treatment of rats with curcumin significantly decreased elevated levels of cTn I and MDA (p < 0.05) in plasma, and increase the levels of SOD (p < 0.05) after CLP. Moreover, curcumin markedly enhanced the myocardial contractility by increasing the decreased EF and FS in rats with sepsis induced by CLP (p < 0.05). In addition, curcumin could alleviate the myocardial inflammation and structure damage of myocardial cells in sepsis induced by CLP. Conclusion: In conclusion, the results from the present study demonstrate that curcumin has the protective effects on cardiac function in rats with sepsis and curcumin could be considered as an effective and safe therapeutic agent for the management of sepsis induced cardiac dysfunction.
Cheng Yang; Keng Wu; Shang-Hai Li; Qiong You
Related Documents :
23449548 - Noninvasive electrocardiographic imaging of arrhythmogenic substrates in humans.
24943298 - Hormonal alterations in heart failure: anabolic impairment in chronic heart failure - d...
23991348 - Gambogic acid moderates cardiac responses to chronic hypoxia likely by acting on the pr...
25114098 - Epigenetic modification at notch responsive promoters blunts efficacy of inducing notch...
3732288 - An external automatic device to detect ventricular fibrillation.
2590918 - Metabolic and haemodynamic changes in the heart during the early phase of cardiopulmona...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-22
Journal Detail:
Title:  Pharmaceutical biology     Volume:  -     ISSN:  1744-5116     ISO Abbreviation:  Pharm Biol     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9812552     Medline TA:  Pharm Biol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliated Hospital of Guang Dong Medical College , Zhanjiang, Guangdong Province , P. R. China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Return of results in translational iPS cell research: considerations for donor informed consent.
Next Document:  A preliminary typology of caregivers and effects on service utilization of caregiver counseling.